Both sides of the same coin? Examining the rise of sponsor-to-sponsor deals

By Troy Ungerman (Toronto) on August 29, 2019 Posted in Corporate finance, M&A

As competition and asset multiples increase, private equity (“PE”) firms must find new ways to put their money to work. One way to create new value is through a sponsor-to-sponsor deal. Sponsor-to-sponsor deals involve PE firms on both sides of a transaction – buy side and sell side. Due to their high cost and complexity, … Continue reading

Don’t be fooled! How traditional M&A differs from digital M&A

By Troy Ungerman (Toronto) on January 17, 2018 Posted in M&A, Technology and innovation

Over the past few years, we have seen a rising trend in digital technologies driving tech M&A deals for both tech and non-tech companies. Technology brings its own set of challenges to the M&A space. The following are some of the many differences between traditional and digital M&A: Wider target list: The list of targets … Continue reading

Private equity investments in healthcare: a look into the future

By Troy Ungerman (Toronto) on September 6, 2017 Posted in M&A, Pharmaceuticals and life sciences

Last year was a record-breaking year for private equity investments in the healthcare industry, with a total disclosed deal value reaching $36.4 billion by the end of 2016. Mid-year reviews of 2017 indicate a downward trend in the number of private equity investments but a significant increase in the value of investments compared to 2016. … Continue reading